What's new for 'JKB_daily1' in PubMed
This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.
Sender's message: Sepsis or genomics or altitude: JKB_daily1
Sent on Wednesday, 2014 February 12Search: (sepsis[MeSH Terms] OR septic shock[MeSH Terms] OR altitude[MeSH Terms] OR genomics[MeSH Terms] OR genetics[MeSH Terms] OR retrotransposons[MeSH Terms] OR macrophage[MeSH Terms]) AND ("2009/8/8"[Publication Date] : "3000"[Publication Date]) AND (("Science"[Journal] OR "Nature"[Journal] OR "The New England journal of medicine"[Journal] OR "Lancet"[Journal] OR "Nature genetics"[Journal] OR "Nature medicine"[Journal]) OR (Hume DA[Author] OR Baillie JK[Author] OR Faulkner, Geoffrey J[Author]))
View complete results in PubMed (results may change over time).
Edit saved search settings, or unsubscribe from these e-mail updates.
|
PubMed Results |
1. | Nature. 2014 Jan 16;505(7483):286-7.Regulation: The FDA is overcautious on consumer genomics.Green RC, Farahany NA. |
PMID: 24436984 [PubMed - indexed for MEDLINE] | |
Related citations | |
2. | Nature. 2014 Jan 16;505(7483):412-6. doi: 10.1038/nature12807. Epub 2013 Dec 8.Muc5b is required for airway defence.Roy MG1, Livraghi-Butrico A2, Fletcher AA3, McElwee MM4, Evans SE4, Boerner RM5, Alexander SN4, Bellinghausen LK4, Song AS4, Petrova YM4, Tuvim MJ4, Adachi R4, Romo I6, Bordt AS7, Bowden MG8, Sisson JH9, Woodruff PG10, Thornton DJ11, Rousseau K11, De la Garza MM4, Moghaddam SJ4, Karmouty-Quintana H 5, Blackburn MR5, Drouin SM5, Davis CW12, Terrell KA12, Grubb BR12, O'Neal WK12, Flores SC13, Cota-Gomez A13, Lozupone CA13, Donnelly JM13, Watson AM13, Hennessy CE13, Keith RC13, Yang IV13, Barthel L14, Henson PM14, Janssen WJ14, Schwartz DA13, Boucher RC12, Dickey BF4, Evans CM15.Author information: AbstractRespiratory surfaces are exposed to billions of particulates and pathogens daily. A protective mucus barrier traps and eliminates them through mucociliary clearance (MCC). However, excessive mucus contributes to transient respiratory infections and to the pathogenesis of numerous respiratory diseases. MUC5AC and MUC5B are evolutionarily conserved genes that encode structurally related mucin glycoproteins, the principal macromolecules in airway mucus. Genetic variants are linked to diverse lung diseases, but specific roles for MUC5AC and MUC5B in MCC, and the lasting effects of their inhibition, are unknown. Here we show that mouse Muc5b (but not Muc5ac) is required for MCC, for controlling infections in the airways and middle ear, and for maintaining immune homeostasis in mouse lungs, whereas Muc5ac is dispensable. Muc5b deficiency caused materials to accumulate in upper and lower airways. This defect led to chronic infection by multiple bacterial species, including Staphylococcus aureus, and to inflammation that failed to resolve normally. Apoptotic macrophages accumulated, phagocytosis was impaired, and interleukin-23 (IL-23) production was reduced in Muc5b(-/-) mice. By contrast, in mice that transgenically overexpress Muc5b, macrophage functions improved. Existing dogma defines mucous phenotypes in asthma and chronic obstructive pulmonary disease (COPD) as driven by increased MUC5AC, with MUC5B levels either unaffected or increased in expectorated sputum. However, in many patients, MUC5B production at airway surfaces decreases by as much as 90%. By distinguishing a specific role for Muc5b in MCC, and by determining its impact on bacterial infections and inflammation in mice, our results provide a refined framework for designing targeted therapies to control mucin secretion and restore MCC. |
PMID: 24317696 [PubMed - indexed for MEDLINE] | |
Related citations | |
![]() |
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home